<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Patients | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta
    name="description"
    content="Information for patients about LiquidMammo™, a non‑invasive microRNA blood test designed to support early breast cancer detection alongside mammography."
  />

  <!-- Styles -->
  assets/css/styles.css

  <!-- Favicon -->
  favicon.png
</head>

<body>

<header class="container">
  <nav>index.html← Home</a></nav>
</header>

<main class="container">

  <h1>Information for Patients</h1>

  <!-- Intro -->
  <section class="section-tight">
    <p>
      LiquidMammo™ is being developed as a simple blood test that works
      <strong>alongside mammography</strong> to strengthen early breast‑cancer detection.
      It is <strong>non‑invasive</strong>, does not require breast compression, and can be added to a
      routine blood draw at your doctor’s office.
    </p>
    <p class="notice" style="margin-top:14px;">
      LiquidMammo is under development as a <strong>CLIA Laboratory Developed Test (LDT)</strong> and is
      <strong>not yet FDA‑cleared/approved</strong>.
    </p>
  </section>

  <!-- Why it's helpful -->
  <section class="panel-light section-tight">
    <h2>Why consider a supplemental test?</h2>

    <p>
      Mammography saves lives, but certain factors can reduce its sensitivity. Dense breast tissue,
      younger age, and individual biological differences can make cancers harder to detect on imaging.
      A molecular signal from the bloodstream—particularly <span class="scientific-term">microRNA</span>
      changes—may offer additional information for you and your clinician.
    </p>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));margin-top:20px;">
      <div class="card-mini">
        <h4>Non‑invasive</h4>
        <p class="small">A standard blood draw—no compression, no radiation, no preparation.</p>
      </div>

      <div class="card-mini">
        <h4>Complements mammography</h4>
        <p class="small">Provides a biological signal where imaging may be limited, especially in dense breasts.</p>
      </div>

      <div class="card-mini">
        <h4>Clinician‑ordered</h4>
        <p class="small">Integrated into clinical care—designed to support, not replace, standard screening guidelines.</p>
      </div>
    </div>
  </section>

  <!-- How it works -->
  <section class="section-tight">
    <h2>How the test works</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card-mini">
        <h4>1 — Simple blood draw</h4>
        <p class="small">
          Your clinician orders the test during a routine appointment. A blood sample is collected
          like any standard lab test.
        </p>
      </div>

      <div class="card-mini">
        <h4>2 — microRNA analysis</h4>
        <p class="small">
          The sample is analyzed for <span class="scientific-term">microRNA</span> patterns associated
          with breast‑cancer biology, including markers that may shift before imaging findings.
        </p>
      </div>

      <div class="card-mini">
        <h4>3 — Clinician‑interpreted results</h4>
        <p class="small">
          Your clinician receives a report with the result and guidance for next steps, such as
          routine follow‑up or additional imaging if indicated.
        </p>
      </div>
    </div>
  </section>

  <!-- Who might benefit -->
  <section class="panel-light section-tight">
    <h2>Who might benefit?</h2>

    <ul class="list-tight">
      <li>People with <strong>dense breasts</strong> (common under age 50).</li>
      <li>Those who want a <strong>non‑invasive supplemental test</strong> alongside mammography.</li>
      <li>Individuals with <strong>family history</strong> or elevated risk who want more frequent monitoring.</li>
      <li>People who find mammograms <strong>painful</strong> or avoid screening due to discomfort.</li>
      <li>Women under 40 who are <strong>not yet recommended</strong> for routine mammograms but have risk factors.</li>
    </ul>

    <p class="small" style="margin-top:10px;">
      Always discuss with your clinician whether a supplemental test is appropriate for your specific risk profile.
    </p>
  </section>

  <!-- Safety & privacy -->
  <section class="section-tight">
    <h2>Safety &amp; privacy</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));">
      <div class="card-mini">
        <h4>Your data</h4>
        <p class="small">
          Only your clinician can order the test. Results are shared with your care team and handled under
          strict privacy and data‑security requirements.
        </p>
      </div>

      <div class="card-mini">
        <h4>Sample handling</h4>
        <p class="small">
          All samples are processed in certified laboratories under controlled conditions with strict
          chain‑of‑custody and quality protocols.
        </p>
      </div>

      <div class="card-mini">
        <h4>No radiation</h4>
        <p class="small">
          LiquidMammo requires no imaging, compression, or radiation—just a routine blood draw.
        </p>
      </div>
    </div>
  </section>

  <!-- Enrollment -->
  <section class="section">
    <h2>How to access the test</h2>

    <p>
      Enrollment is currently limited as we complete our validation studies. You can sign up for updates or
      participate in early access through your clinician.
    </p>

    <div style="margin-top:18px;display:flex;gap:12px;flex-wrap:wrap;">
      contact.html#patientsJoin Early Access List</a>
      clinicians.html#enrollClinician Enrollment</a>
    </div>
  </section>

</main>

<footer>
  <div class="container footer-grid">
    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC, and operates out of LabCentral,
        Cambridge, MA (MIT innovation ecosystem).
      </p>
    </div>
    <div class="footer-logo" style="justify-content:flex-end;text-align:right">
      assets/logos/multiomics-logo.png
      <div class="footer-note" style="line-height:1.2">Developed by<br/>MultiOmics Inc.</div>
    </div>
  </div>

  <div class="container footer-note">
    © <script>document.write(new Date().getFullYear())</script> MultiOmics Inc. •
    privacy.htmlPrivacy &amp; Compliance</a> •
    contact.htmlContact</a>
  </div>
</footer>

</body>
</html>

